• Chlamydia trachomatis and Neisseria gonorrhoeae NA, Urine
  • Pneumocystis Smear
  • Triiodothyronine (T3), Reverse
  • Saccharomyces cerevisiae Antibody, IgG
  • Aspergillus (Galactomannan) Antigen, Serum
  • Interleukin 28 B (IL28B) Gene Variation Analysis
  • Toxoplasma Gondii IgG and IgM, CSF
  • Fentanyl, Urine
  • Psychosine, Blood
  • Cancer Antigen (CA) 19-9, Peritoneal Fluid
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /HIV Drug Resistance Phenotyping Assay (Phenosense)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

HIV Drug Resistance Phenotyping Assay (Phenosense)
Medical Test

Methodology
Access to HIV Drug Resistance Phenotyping Assay (Phenosense) is restricted.
Loading...